Dana-Farber Cancer Institute /ID# 166886

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling